Howard Capital Management LLC increased its position in Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 8,465.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 174,983 shares of the biotechnology company’s stock after buying an additional 172,940 shares during the quarter. Axon Enterprise comprises about 0.8% of Howard Capital Management LLC’s investment portfolio, making the stock its 25th biggest position. Howard Capital Management LLC’s holdings in Axon Enterprise were worth $73,934,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Pure Financial Advisors LLC grew its position in Axon Enterprise by 6.7% during the fourth quarter. Pure Financial Advisors LLC now owns 364 shares of the biotechnology company’s stock valued at $207,000 after acquiring an additional 23 shares during the period. Keel Point LLC raised its holdings in shares of Axon Enterprise by 4.4% in the 1st quarter. Keel Point LLC now owns 599 shares of the biotechnology company’s stock worth $254,000 after purchasing an additional 25 shares during the period. Bridgewater Advisors Inc. raised its holdings in shares of Axon Enterprise by 4.4% in the 2nd quarter. Bridgewater Advisors Inc. now owns 616 shares of the biotechnology company’s stock worth $352,000 after purchasing an additional 26 shares during the period. Roman Butler Fullerton & Co. lifted its stake in shares of Axon Enterprise by 2.4% in the 1st quarter. Roman Butler Fullerton & Co. now owns 1,278 shares of the biotechnology company’s stock valued at $500,000 after purchasing an additional 30 shares in the last quarter. Finally, 44 Wealth Management LLC lifted its stake in shares of Axon Enterprise by 6.0% in the 1st quarter. 44 Wealth Management LLC now owns 530 shares of the biotechnology company’s stock valued at $225,000 after purchasing an additional 30 shares in the last quarter. Institutional investors and hedge funds own 79.08% of the company’s stock.
Axon Enterprise Stock Down 6.4%
Shares of AXON traded down $26.90 during mid-day trading on Friday, reaching $390.29. 1,420,893 shares of the stock traded hands, compared to its average volume of 983,036. The stock has a fifty day simple moving average of $501.59 and a 200 day simple moving average of $474.43. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $764.02. The company has a quick ratio of 1.80, a current ratio of 2.15 and a debt-to-equity ratio of 0.47. The firm has a market cap of $31.71 billion, a price-to-earnings ratio of 161.95, a P/E/G ratio of 7.85 and a beta of 1.44.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last announced its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.04. The business had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a net margin of 6.19% and a return on equity of 2.84%. The business’s quarterly revenue was up 35.3% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.12 earnings per share. Sell-side analysts expect that Axon Enterprise, Inc will post 2.12 EPS for the current fiscal year.
Insider Activity
In other news, insider Isaiah Fields sold 1,017 shares of Axon Enterprise stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $480.45, for a total transaction of $488,617.65. Following the sale, the insider directly owned 56,264 shares of the company’s stock, valued at approximately $27,032,038.80. The trade was a 1.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the sale, the president directly owned 296,974 shares in the company, valued at approximately $170,590,774.82. The trade was a 5.35% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last 90 days, insiders have sold 47,397 shares of company stock worth $26,722,984. 4.20% of the stock is owned by corporate insiders.
Analyst Ratings Changes
A number of analysts have recently issued reports on AXON shares. Weiss Ratings reiterated a “hold (c-)” rating on shares of Axon Enterprise in a report on Wednesday, August 5th. UBS Group raised their price target on shares of Axon Enterprise from $440.00 to $600.00 and gave the company a “neutral” rating in a report on Thursday, August 6th. Raymond James Financial set a $675.00 price target on shares of Axon Enterprise in a research report on Thursday. Needham & Company LLC reiterated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, September 2nd. Finally, TD Cowen reissued a “buy” rating on shares of Axon Enterprise in a research report on Tuesday. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and two have assigned a Hold rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $718.47.
Read Our Latest Stock Analysis on AXON
Axon Enterprise Profile
Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.
The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.
Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.
Further Reading
- Five stocks we like better than Axon Enterprise
- ManpowerGroup Stock Sinks on Q3 Results, But Fundamentals Stay Solid
- Does the AI Selloff Put Alphabet’s Breakout in Doubt?
- Bank Earnings Are Mixed—These 2 ETFs Offer Very Different Paths to a Recovery
- 3 Stocks Delivering Bigger Dividends Despite Market Uncertainty
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
